FahnSMarsdenCDCalneDB.
Classification and investigation of dystonia. In:
MarsdenCDFahnS,
eds. Movement disorders2, vol 7. Butterworths International Medical Reviews, 1987:
332–358
2.
SchwalbeW.
Eine eigentumliche tonische Kramfform mit hysterischen
Symptomen. Inaugural Dissertation, Berlin,
1908
3.
PodivinskyF.
Torticollis. In: VinkenPJBruynGW,
eds. Handbook of Clinical Neurology, vol. 6.
Amsterdam: North
Holland, 1968:
567–603
4.
MarsdenCDObesoJAZarranzJJLangAE.
The anatomical basis of symptomatic hemidystonia.
Brain1986; 108:
461–83
5.
FahnSMarsdenCD.
Treatment of dystonia. In: MarsdenCDFahnS,
eds. Movement disorders 2, vol. 7.
Butterworths International Medical Reviews,
1987: 359–82
6.
KramerPLDeLeonDOzeliusL,
et al.Dystonia in Ashkenazim jews is located on chromosome
9q32–34. Ann Neurol1990; 27:
114–20
7.
MarsdenCDHarrisonMJGBundeyS.
Natural history of idiopathic torsion dystonia.
Adu Neurol1976; 14:
177–87
8.
JahanshahiMMarionMHMarsdenCD.
Natural history of adult onset idiopathic torticollis.
Arch Neurol1990; 47:
548–52
9.
FletcherNAHardingAEMarsdenCD.
A genetic study of idiopathic torsion dystonia in the UK.
Brain1990; 113:
379–95
10.
CooperIS.
20-year follow-up of the neurosurgical treatment of dystonia musculorum
deformans. Adv Neurol1976; 14:
423–52
11.
AndersonTJRivestJStellR,
et al.Botulinum toxin treatment of spasmodic torticollis.
J R Soc Med1992; 85:
524–9
12.
HathewayCL.
Bacterial sources of clostridial neurotoxins. In:
SimpsonLL,
ed. Botulinum neurotoxin and tetanus toxin.
New York: Academic
Press, 1989:
4–6
13.
LeesAJTurjanskiNRivestJWhurrRLorchMBrookesG.
Treatment of cervical dystonia, hand spasms and laryngeal dystonia with
botulinum toxin. J Neurol1992; 239:
1–4
14.
JankovicJSchwartzK.
Botulinum toxin for cervical dystonia.
Neurology1990; 40:
277–80
15.
HambletonPCohenHEPalmerBJMellingJ.
Antitoxins and botulinum toxin treatment.
BMJ1992; 304:
959–60
16.
ElstonJS.
The clinical use of botulinum toxin. Semin
Ophthalmol1988; 4:
249–60